Should All Women With Breast Cancer Be Tested forBRCAMutations at the Time of Diagnosis?

The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer

(2011) Steven A. Narod   BREAST CANCER RESEARCH AND TREATMENT

Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy

(2011) Amir Sonnenblick et al.   CANCER BIOLOGY & THERAPY

Is Screening With Magnetic Resonance Imaging in BRCA Mutation Carriers a Safe and Effective Alternative to Prophylactic Mastectomy?

(2011) Monika L. Burness et al.   JOURNAL OF CLINICAL ONCOLOGY

Breast Cancer Prognosis inBRCA1andBRCA2Mutation Carriers: An International Prospective Breast Cancer Family Registry Population-Based Cohort Study

(2011) Pamela J. Goodwin et al.   JOURNAL OF CLINICAL ONCOLOGY

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

(2010) Andrew Tutt et al.   LANCET

Tumor size and survival in breast cancer—a reappraisal

(2010) William D. Foulkes et al.   Nature Reviews Clinical Oncology

Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy

(2009) Tomasz Byrski et al.   JOURNAL OF CLINICAL ONCOLOGY